No Royalties. Subject to the Closing, the Assignor releases Pluristem from any obligation to pay to the Assignor any royalties, lump sum payments or other consideration received due to any sublicense granted by Pluristem (“Royalties”) under Section 4 of the License Agreement. The Assignor warrants and represents that as of the date hereof, it shall not raise any claim, allegation and/or assertion with respect to Royalties pursuant to Section 4 of the Agreement, or have any right to Royalties from Pluristem henceforth and/or as otherwise deemed by Assignor as due prior to or following the date hereof, including, without limitation, in connection with the Patent, the Intellectual Property, the Products and/or any derivatives thereof. Pluristem represents that until the date hereof, other than the sublicense with Stem Cells Innovations Inc. no other sublicense transactions were concluded.
Appears in 2 contracts
Sources: Assignment Agreement (Pluristem Life Systems Inc), Assignment Agreement (Pluristem Life Systems Inc)